WS
RMD icon

Wedbush Securities’s ResMed RMD Stock Holding History

Wedbush Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$770K Sell
3,949
-97
-2% -$20.1K 0.02% 574
2026
Q1 		$908K Buy
4,046
+117
+3% +$29.2K 0.03% 483
2025
Q4 		$946K Buy
3,929
+139
+4% +$35.5K 0.03% 459
2025
Q3 		$1.04M Buy
3,790
+132
+4% +$36.1K 0.03% 419
2025
Q2 		$944K Buy
3,658
+391
+12% +$93.3K 0.03% 429
2025
Q1 		$731K Sell
3,267
-60
-2% -$14K 0.03% 479
2024
Q4 		$761K Buy
3,327
+461
+16% +$111K 0.03% 461
2024
Q3 		$700K Sell
2,866
-788
-22% -$176K 0.03% 484
2024
Q2 		$699K Buy
3,654
+1,022
+39% +$207K 0.03% 489
2024
Q1 		$521K Buy
+2,632
New +$482K 0.02% 625
2021
Q4 		– Sell
-811
Closed -$214K – 1223
2021
Q3 		$214K Sell
811
-30
-4% -$8.2K 0.01% 1030
2021
Q2 		$207K Buy
+841
New +$177K 0.01% 1043
2016
Q1 		– Sell
-4,300
Closed -$231K – 795
2015
Q4 		$231K Hold
4,300
– – 0.04% 514
2015
Q3 		$219K Buy
+4,300
New +$231K 0.04% 498

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wedbush Securities's RMD Position: Q2 2026 in Review

Wedbush Securities reduced its ResMed (RMD) stake by 2.4% in Q2 2026, selling an estimated $20.1K and leaving 3,949 shares worth $770K. The position accounts for 0.02% of the portfolio, ranked #574.

Wedbush Securities first reported a position in RMD in Q3 2015 and has held it in 14 quarters since. The position peaked at $1.04M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wedbush Securities held 3,949 shares of ResMed worth $770K as of Q2 2026.
  • Wedbush Securities sold 97 ResMed shares in Q2 2026, an estimated $20.1K.
  • ResMed made up 0.02% of Wedbush Securities's portfolio in Q2 2026, its #574 holding.
  • Wedbush Securities first reported a position in ResMed in Q3 2015 and has held it in 14 quarters since.
  • Wedbush Securities's ResMed position peaked at $1.04M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.